Dr. Anjali Shah, MD

NPI: 1831101757
Total Payments
$5,369
2024 Payments
$630.03
Companies
29
Transactions
196
Medicare Patients
1,518
Medicare Billing
$179,725

Payment Breakdown by Category

Food & Beverage$3,941 (73.4%)
Travel$1,358 (25.3%)
Education$69.90 (1.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,941 190 73.4%
Travel and Lodging $1,358 4 25.3%
Education $69.90 2 1.3%

Top Paying Companies

Company Total Records Latest Year
Amgen Inc. $1,759 15 $0 (2023)
AstraZeneca Pharmaceuticals LP $806.77 50 $0 (2024)
Novo Nordisk Inc $427.41 32 $0 (2024)
Lilly USA, LLC $352.07 21 $0 (2024)
Allergan, Inc. $261.43 5 $0 (2020)
Boehringer Ingelheim Pharmaceuticals, Inc. $218.33 12 $0 (2024)
GlaxoSmithKline, LLC. $174.18 11 $0 (2023)
Impulse Dynamics (USA) Inc. $159.90 1 $0 (2023)
Merck Sharp & Dohme LLC $159.48 7 $0 (2024)
Janssen Pharmaceuticals, Inc $149.20 3 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $630.03 30 AstraZeneca Pharmaceuticals LP ($154.51)
2023 $1,026 47 Impulse Dynamics (USA) Inc. ($159.90)
2022 $586.36 33 AstraZeneca Pharmaceuticals LP ($164.79)
2021 $598.71 38 AstraZeneca Pharmaceuticals LP ($179.18)
2020 $258.18 14 AstraZeneca Pharmaceuticals LP ($101.78)
2019 $295.44 15 Janssen Pharmaceuticals, Inc ($104.16)
2018 $1,715 12 Amgen Inc. ($1,655)
2017 $259.94 7 Allergan Inc. ($176.25)

All Payment Transactions

196 individual payment records from CMS Open Payments — Page 2 of 8

Date Company Product Nature Form Amount Type
03/18/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $13.85 General
Category: Respiratory
03/11/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $13.36 General
Category: Diabetes
02/27/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $15.98 General
Category: Diabetes
02/14/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $13.66 General
Category: Respiratory
02/07/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $21.86 General
Category: Diabetes
12/20/2023 Boehringer Ingelheim Pharmaceuticals, Inc. TRADJENTA (Drug), JARDIANCE, SYNJARDY Food and Beverage In-kind items and services $16.11 General
Category: DIABETES
12/19/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $19.43 General
Category: NEUROSCIENCE
12/18/2023 Novo Nordisk Inc Food and Beverage In-kind items and services $16.56 General
12/13/2023 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $30.80 General
Category: Endocrinology
12/04/2023 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $19.08 General
Category: Inflammation
12/01/2023 KCI USA, Inc. ACTIV.A.C. iOn PROGRESS (Device), PREVENA, V.A.C. VERAFLO Food and Beverage Cash or cash equivalent $89.84 General
Category: Negative Pressure Systems & Dressings
11/15/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $24.86 General
Category: NEUROSCIENCE
11/08/2023 Merck Sharp & Dohme LLC DIFICID (Drug) Food and Beverage In-kind items and services $20.29 General
Category: INFECTIOUS DISEASE
11/01/2023 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $18.28 General
Category: Diabetes
10/26/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $19.96 General
Category: Cardio-renal
10/18/2023 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $15.42 General
Category: Diabetes
10/12/2023 Novo Nordisk Inc Food and Beverage In-kind items and services $12.12 General
10/05/2023 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $15.04 General
Category: Inflammation
09/27/2023 Merck Sharp & Dohme LLC DIFICID (Drug) Food and Beverage In-kind items and services $23.50 General
Category: INFECTIOUS DISEASE
09/13/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.57 General
Category: Cardiovascular and Metabolism
09/06/2023 Teleflex LLC UROLIFT (Device) Food and Beverage In-kind items and services $26.74 General
Category: Interventional Urology
08/24/2023 Novo Nordisk Inc Food and Beverage In-kind items and services $19.61 General
08/18/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $19.02 General
Category: Cardiovascular and Metabolism
08/09/2023 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $26.77 General
Category: Oncology
07/27/2023 Kowa Pharmaceuticals America, Inc. SEGLENTIS (Drug) Food and Beverage In-kind items and services $13.00 General
Category: PAIN MANAGEMENT

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 575 859 $178,734 $53,098
2022 8 314 753 $100,002 $44,426
2021 9 333 828 $76,704 $43,148
2020 10 296 761 $81,331 $39,053
Total Patients
1,518
Total Services
3,201
Medicare Billing
$179,725
Procedure Codes
39

All Medicare Procedures & Services

39 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 188 362 $106,924 $27,959 26.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 100 135 $27,551 $7,803 28.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 36 36 $16,114 $4,495 27.9%
90662 Influenza vaccine split virus, preservative free Office 2023 62 62 $3,705 $3,630 98.0%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 12 12 $8,508 $3,390 39.8%
G0008 Administration of influenza virus vaccine Office 2023 70 71 $2,020 $1,942 96.1%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2023 12 12 $5,522 $1,717 31.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 14 14 $4,384 $796.66 18.2%
96372 Injection of drug or substance under skin or into muscle Office 2023 26 63 $2,431 $747.29 30.7%
G0009 Administration of pneumococcal vaccine Office 2023 12 12 $328.20 $321.60 98.0%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 19 19 $883.42 $224.82 25.4%
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg Office 2023 24 61 $366.00 $72.47 19.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 92 369 $74,556 $35,098 47.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 38 43 $8,597 $3,045 35.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 18 18 $5,686 $2,028 35.7%
90662 Influenza vaccine split virus, preservative free Office 2022 21 21 $1,260 $1,236 98.1%
96372 Injection of drug or substance under skin or into muscle Office 2022 35 101 $3,746 $1,158 30.9%
36410 Insertion of needle into vein (3 years or older) Office 2022 53 80 $2,000 $1,086 54.3%
G0008 Administration of influenza virus vaccine Office 2022 24 24 $935.20 $657.90 70.3%
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg Office 2022 33 97 $3,221 $116.56 3.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 62 352 $57,004 $34,355 60.3%
90662 Vaccine for influenza for injection into muscle, split virus, preservation free Office 2021 40 40 $2,636 $2,601 98.7%
36410 Insertion of needle into vein, patient 3 years or older Office 2021 57 143 $3,575 $1,927 53.9%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 13 13 $3,250 $1,724 53.0%
G0008 Administration of influenza virus vaccine Office 2021 43 43 $1,505 $800.66 53.2%

About Dr. Anjali Shah, MD

Dr. Anjali Shah, MD is a Family Medicine healthcare provider based in Newburgh, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831101757.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anjali Shah, MD has received a total of $5,369 in payments from pharmaceutical and medical device companies, with $630.03 received in 2024. These payments were reported across 196 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,941).

As a Medicare-enrolled provider, Shah has provided services to 1,518 Medicare beneficiaries, totaling 3,201 services with total Medicare billing of $179,725. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Newburgh, NY
  • Active Since 08/12/2006
  • Last Updated 06/17/2008
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1831101757

Products in Payments

  • Repatha (Biological) $1,628
  • FARXIGA (Drug) $685.06
  • TRADJENTA (Drug) $218.33
  • TRULICITY (Drug) $165.53
  • OPTIMIZER (Device) $159.90
  • Cologuard Collection Kit (Device) $141.58
  • MOUNJARO (Drug) $133.58
  • XARELTO (Drug) $131.29
  • ANORO (Drug) $131.13
  • BOTOX-UROLOGY (Drug) $109.37
  • Ozempic (Drug) $97.08
  • Rybelsus (Drug) $96.47
  • DIFICID (Drug) $95.42
  • XIFAXAN (Drug) $92.58
  • ACTIV.A.C. iOn PROGRESS (Device) $89.84
  • Xhance (Drug) $82.35
  • BOTOX COSMETIC (Biological) $69.90
  • NAMZARIC (Drug) $66.88
  • Kerendia (Drug) $64.63
  • Otezla (Drug) $63.55

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Newburgh